|
Market Closed -
Bombay S.E.
11:27:32 22/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 117.95 INR | +1.86% |
|
-7.74% | +187.19% |
| Market Cap | 64.63B 682M 609M 562M 510M 958M 972M 6.77B 2.67B 33.86B 2.56B 2.51B 107B | P/E 2025 |
21.8x | P/E 2026 | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 66.17B 699M 624M 575M 523M 980M 995M 6.93B 2.73B 34.67B 2.62B 2.57B 110B | EV / Sales 2025 |
1.45x | EV / Sales 2026 | 1.11x |
| Free-Float |
57.95% | Yield 2025 |
0.42% | Yield 2026 | 0.59% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| MOREPENLAB | Delayed | |
NSE India S.E.
| MOREPENLAB | Delayed |
| 1 day | +1.86% | ||
| 1 week | -7.74% | ||
| Current month | -6.39% | ||
| 1 month | -3.60% | ||
| 3 months | +107.51% | ||
| 6 months | +182.65% | ||
| Current year | +187.19% |
| 1 week | 110.05 |  | 127.6 |
| 1 month | 110.05 | | 150.8 |
| Current year | 33.44 | | 150.8 |
| 1 year | 33.44 | | 150.8 |
| 3 years | 31.31 | | 150.8 |
| 5 years | 23.65 | | 150.8 |
| 10 years | 7.21 | | 150.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 30/06/2026 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 31/01/1992 |
| Director of Finance/CFO | 59 | 02/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 31/01/1992 |
| Director/Board Member | 58 | 12/08/2019 | |
Savita
BRD | Director/Board Member | - | 21/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.86% | -7.74% | +139.88% | +236.71% | 672M | |
| +2.83% | +4.40% | +60.84% | +126.60% | 1,133B | |
| +3.81% | +5.66% | +38.70% | +76.77% | 621B | |
| +0.14% | +0.63% | +24.71% | +97.05% | 503B | |
| +0.03% | +5.72% | +39.64% | +64.06% | 379B | |
| -1.76% | +1.41% | +68.06% | +42.47% | 370B | |
| +1.58% | +5.07% | +23.26% | +51.98% | 292B | |
| +2.90% | +5.53% | +4.06% | +24.45% | 262B | |
| +2.04% | +3.05% | +51.12% | +63.80% | 237B | |
| +2.36% | -0.11% | +29.42% | +102.67% | 190B | |
| Average | +1.47% | +1.95% | +47.97% | +88.66% | 398.87B | |
| Weighted average by Cap. | +1.69% | +3.73% | +42.94% | +84.33% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18.12B 191M 171M 157M 143M 268M 273M 1.9B 747M 9.49B 718M 702M 30.07B | 18.06B 191M 170M 157M 143M 268M 272M 1.89B 745M 9.46B 716M 700M 29.97B |
| Net income | 1.18B 12.46M 11.12M 10.26M 9.32M 17.49M 17.76M 124M 48.69M 618M 46.77M 45.77M 1.96B | 949M 10.02M 8.94M 8.25M 7.49M 14.06M 14.27M 99.36M 39.14M 497M 37.6M 36.79M 1.57B |
| Net Debt | -928K -9.8K -8.74K -8.07K -7.33K -13.75K -13.96K -97.19K -38.28K -486K -36.77K -35.99K -1.54M | 1.54B 16.24M 14.49M 13.37M 12.15M 22.79M 23.14M 161M 63.45M 806M 60.94M 59.64M 2.55B |
Employees
1,919
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | ₹117.95 | +1.86% | 338,973 |
| 21/10/26 | ₹115.80 | -4.97% | 290,203 |
| 19/10/26 | ₹121.85 | -1.42% | 273,240 |
| 16/10/26 | ₹123.60 | -1.59% | 237,272 |
| 15/10/26 | ₹125.60 | -1.76% | 378,499 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
